Crossmark

Combined transarterial chemoembolization and radiofrequency ablation for subphrenic versus nonsubphrenic hepatocellular carcinoma: a propensity score matched study

Crossref DOI link: https://doi.org/10.1007/s00261-021-03291-6

Published Online: 2021-09-28

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kim, Jun Gon

Cho, Sung Ki https://orcid.org/0000-0001-6900-0197
Hyun, Dongho

Shin, Sung Wook

Park, Kwang Bo

Park, Hong Suk

Choo, Sung Wook

Do, Young Soo

Woo, Sook-Young

Baek, Sun-Young
License Information

Text and Data Mining valid from 2021-09-28

Version of Record valid from 2021-09-28
More Information

Article History

Received: 10 August 2021

Revised: 17 September 2021

Accepted: 20 September 2021

First Online: 28 September 2021

Declarations

:

: The authors declare that they have no conflict of interest.

: This study has obtained IRB approval from Samsung Medical Center and the need for informed consent was waived.

: For this type of study, formal consent is not required. For this type of study, consent for publication is not required.

Document is current

Any future updates will be listed below